W hen diagnosed with diabetic macular edema (DME) in 2017, Sarah Castaneda, 41, thought she would lose her eyesight completely. At least, that’s what her doctor told her would happen if she didn’t ...

The FDA issued a third complete response letter for ONS-5010/Lytenava, requesting confirmatory efficacy evidence for wet AMD treatment. Lytenava is an ophthalmic bevacizumab formulation, potentially ...

For generations, adults with amblyopia were told their vision loss was permanent, a childhood problem that medicine could not ...

FDA approvals in 2025 introduced novel therapies and devices across ophthalmic subspecialties, emphasizing sustained efficacy ...

Bronwyn Anderson has wet age-related macular degeneration and has regular eye injections to help preserve her remaining vision. Bronwyn Anderson remembers looking at her husband and feeling “horrified ...

Big Machine Racing announced today that retina surgeon and stock car driver Dr. Patrick Staropoli will join the team full ...

X-linked retinoschisis gene replacement therapy, aiming to improve retinal architecture and visual function in young male ...

Retinal vascular obstruction is an eye disease that causes vision loss by clogging blood vessels that supply nutrition and oxygen to the retina. According to the Health Insurance Review and Assessment ...

The top read ophthalmology articles of 2025 focused on a variety of topics within the field, including links between ...

A study by LV Prasad Eye Institute highlights rising antimicrobial resistance in post-cataract infections, with aggressive ...

A 63-year-old Vietnamese-speaking man with a history of scleritis in the left eye, epiretinal membrane, dry eye syndrome and ...

For more than 35 years, Carty Eye Associates has been that kind of place, a practice where families send their parents, their ...